CLINICAL ASPECTS

Patient Characteristics
Vulvar Paget disease is uncommon and accounts for 2.5% of all vulvar malignancies [10] . It affects mainly white patients aged between 40 and 80 years. The median age is approximately 70 [10] [11] [12] [13] both for intraepithelial and invasive vulvar Paget disease patients [14] . No element in patients' family, environmental, or social histories suggested an etiology or propensity for developing vulvar Paget disease.
Symptomatology
Symptoms are not specific; most patients report itching, burning, and soreness. A small subset of patients may be asymptomatic. Presence of vulvar pain, bleeding, and tumor formation are reported to be more common in patients affected by invasive disease [14, 15] .
Macroscopic Appearance
Vulvar Paget disease presents as a variety of clinical lesions that may occur over a protracted course. Initially it is velvety, soft, and red or bright pink with scattered white islands of hyperkeratosis ( Figure 1 ). The lesions become erythematous, plaque like, and desquamating especially when located in dry areas. Rarely the appearance is ulcerated ( Figure 2 ). Cases of pigmented vulvar Paget disease are reported [16] . The borders appear irregular, slightly elevated, and sharply demarcated [17, 18] . The visible borders of vulvar Paget disease are often misleading as Paget cells may spread along the basal layers of normal appearing skin with multicentric foci [18] [19] [20] [21] [22] . Involvement may be extensive including the perianal region, genitocrural, and inguinal folds [23] . Clinical examination should determine the presence of periurethral and perianal lesions ( Figure 3 ). In these cases an involvement of the skin by a noncutaneous internal neoplasm may occur (see below). 
Differential Diagnosis
Macroscopic aspects of vulvar Paget disease lesions are often confused with lichen sclerosus, dermatophytosis, candidiasis, contact dermatitis, psoriasis, seborrheic dermatitis, and squamous vulvar intraepithelial neoplasia. An accurate anamnesis, a clinical examination to search for similar lesions elsewhere on the body and a biopsy with the appropriate use of immunohistochemistry, will confirm a vulvar Paget disease diagnosis.
HISTOPATHOLOGICAL ASPECTS
Histogenesis
Among the theories discussed in the literature regarding the histogenesis of vulvar Paget disease [11, 24, 25] the multifocal origin was generally accepted. This assumption was based on concepts of skin embryology. Woodruff and Kaufman hypothesized that Paget cells derive from undifferentiated basal cells of the stratum germinativum [26, 27] , the stem cells that, except for the melanocytes, are the origin of all the cells of the epidermis and its appendages [28] . This embryology-based hypothesis explained the multifocal primary origin of intraepithelial Paget disease with or without associated underlying adenocarcinoma and does not contradict the fact that intraepithelial disease can remain in situ for a long period of time before invading the dermis [17, 24, 25, 29, 30] .
The origin of vulvar Paget disease from supernumerary mammary glands has also been suggested [31] . Current evidence, however, supports that these mammarylike glands are not supernumerary mammary glands but rather vulvar specialized anogenital glands closely related to eccrine glands [32] .
Recently Wilkinson and Brown have proposed a classification of vulvar Paget disease that takes into account its heterogenous origin. This classification defines two distinct groups of vulvar Paget disease, those of cutaneous origin and those of noncutaneous origin. The latter group includes Paget disease of urothelial, anorectal, and other noncutaneous sites [33] . This classification is supported by immunohistochemical studies to distinguish these Paget lesions and aids in understanding the otherwise apparent conflicting findings in various reports of Paget disease. 4). The cytoplasm contains neutral and acid mucopolysaccharides that stain positively with mucicarmine, aldehyde fuchsin, Alcian blue at pH 2.5, Periodic acid/Schiff, which is resistant to diastase digestion [17, 36] , and it is usually also positive to colloidal iron and sialomucin staining [37] . Mitotic figures do not frequently occur [38] .
Histopathology
Involvement of the pilosebaceous units and sweat glands may be seen [34, [39] [40] [41] . The occurrence of epidermal lesions adjacent to anogenital Paget disease has been recently studied [42] .
As opposed to intraepithelial vulvar Paget disease, invasive disease shows a discontinuous basement membrane in the area of invasion with groups of Paget cells protruding into the underlying stroma [38] . These cells appear more anaplastic and react weakly with mucicarmine stain [39, 41] .
Differential Diagnosis
Histologic differential diagnosis of vulvar Paget disease includes pagetoid melanoma, vulvar squamous intraepithelial neoplasia, sebaceous carcinoma, Merkel cell carcinoma with pagetoid intraepidermal spread, eccrine porocarcinoma, tricholemmal carcinoma, cutaneous T-cell lymphoma, Pagetoid Spitz nevus, and histiocytosis X [43] [44] [45] .
It is crucial to exclude stromal invasion, underlying invasive adenocarcinoma, and vulvar pagetoid spread of associated adjacent noncutaneous adenocarcinoma that severely affect patients' prognosis. On routine histology some differences can be found between Paget cells of primary vulvar cutaneous origin and those of anorectal and urothelial origin, with secondary vulvar spread [33] . Immunohistochemistry will help in the diagnosis.
Immunohistochemistry
The immunohistochemical characteristics of Paget cells in primary intraepithelial vulvar Paget disease are summarized in Table 1 together with the characteristics of normal skin [24, 29, 43, [46] [47] [48] [49] [50] [51] [52] [53] . From these findings, intraepidermal Paget cells are proved to be differentiated mainly toward the ductal portion (CEA, II-7, B6.2 positivity), although in some instances partially toward the secretory portion of the sweat glands (GCDFP-15, CD15, PKK1 positivity). The question of whether Paget cells show apocrine differentiation is still controversial, but they do not show complete apocrine differentiation nor do they show eccrine differentiation.
Immunohistochemistry provides reliable assistance in the differential diagnosis of vulvar Paget disease against pagetoid melanoma using S100 (a calcium-binding protein), HMB45 (a melanoma-specific cytoplasmic antigen), and Melan-A as melanocytic markers [16, [54] [55] [56] and against vulvar squamous intraepithelial neoplasia as the panel of keratins expressed by Paget cells differs from the cells of adjacent epidermis [57] . In particular the strong immunoreactivity for keratins 7 and 19 facilitates the identification of small foci of intraepithelial and invasive vulvar Paget disease lesions [58] [59] [60] .
Data from the literature underline that Paget cells in primary cutaneous vulvar Paget disease are for the most part immunoreactive for cytokeratin 7, CEA, and GCDFP-15 ( Figure 5 ). Less frequently they are focally reactive for cytokeratin 20. This immunophenotype (CK 7 + , CK 20 -/+ , GCDFP 15 + ) assists in the distinction between primary vulvar Paget disease and less common pagetoid involvement of vulvar skin by a noncutaneous internal neoplasm. This distinction is of utmost clinical importance as therapeutic approaches and prognoses of these diseases are quite different, despite their similar clinical and routine histopathologic findings.
The most common cause of noncutaneous vulvar pagetoid involvement is perianal spread from an associated anorectal adenocarcinoma. These cases, different from primary vulvar Paget disease, typically express cytokeratin 20 and, at the same time, immunohistochemical reactions for GCDFP15 are negative [57, [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] .
The second most common cause of noncutaneous Paget disease is related to direct extension or intraepithelial epidermotropic extension to the vulvar skin or Other cases of vulvar secondary involvement from adenocarcinoma of the cervix, endometrium, and ovary are described as single case reports.
Electron Microscopy
Electron microscopy shows that vulvar Paget disease cells differ markedly in structure from the keratinocytes of the surrounding epidermis, and cell cytoplasm appears more electron lucent. Two cell variants are present, secretory and nonsecretory, the former being more common with abundant secretory granules, welldeveloped Golgi complex, and profiles of endoplasmic reticulum. A small number of cells do not contain se- 
DNA Ploidy
The prognostic role of ploidy in vulvar Paget disease has been analyzed in four different series [59, [83] [84] [85] . Twenty-five of 59 cases of intraepithelial vulvar Paget disease (42%) were nondiploid and 8 of 21 invasive lesions (38%) were diploid. The recurrence rate was 26% (11/42) in diploid lesions and 31% (12/38) in nondiploid lesions. From these data we cannot infer a significant value of tumor DNA ploidy in predicting either recurrence or invasion.
Viruses, Oncogenes, and Tumor Markers
Some of the characteristics of vulvar Paget disease, such as multicentricity, a tendency to recur, and rare invasiveness, recall virus-associated epithelial atypia. No study has evidenced human papillomavirus (HPV) antigen or HPV DNA in the cells of vulvar Paget disease specimens [42, [86] [87] [88] [89] , so that the participation of HPV infection in the pathogenesis of the disease is unlikely. On the other hand neither p53 gene mutations nor loss of heterozygosity at selected loci were detected in Paget cells [89] . Immunohistochemical analyses for c-erb-B2 antigen [22, 30, 90] , bcl2, and p53 protein expression [59, 84, 91, 92] have revealed conflicting and inconclusive results. The role of these oncogenes is still undetermined and without an actual role in indicating patients at greater risk of recurrence or invasive neoplasm. No data support the use of serum tumor markers SCC, LSA, and Ca 19-9 to predict disease occurrence or recurrence [93] .
The underlying genetic defects in extramammary Paget disease are probably different from those in other epithelial malignancies. Further molecular genetic studies may help to cast light on the peculiar biological behavior of vulvar Paget disease. 
VULVAR PAGET DISEASE PROPOSED SUBCLASSIFICATION
VULVAR PAGET DISEASE AND INVASIVE NEOPLASMS
In the past decades there was considerable confusion about the relationship between vulvar Paget disease and associated malignancies. This term has been used to indicate: 1) the presence of dermal invasion; 2) association with underlying skin appendage invasive adenocarcinoma; and 3) association with carcinoma of adjacent structures (vulva-vagina), regional internal organ (colon-rectum, urinary tract), unrelated visceral organ (uterus, ovary, stomach), or carcinomas at a distant site (breast, lung) occurring before, contemporaneously, or after vulvar Paget disease diagnosis.
In Table 2 the studies where a distinction among the above-cited subgroups was feasible are reported [11, [13] [14] [15] 20 
Primary Vulvar Paget Disease with Stromal Invasion
Dermal invasion may evolve from primary vulvar intraepithelial Paget disease over time. The subset of minimally invasive vulvar Paget disease (stromal invasion Յ 1 mm) [20, 104] represents direct histologic evidence that intraepithelial vulvar Paget disease has the potential to invade as intraepithelial and that invasive components are composed of the same cells with identical immunophenotype [59] . The development of invasive vulvar Paget disease is reported up to 10 years after initial treatment for intraepithelial vulvar Paget disease [20] . In most invasive vulvar Paget disease an extensive intraepithelial skin involvement (Ն 10 cm in diameter) is reported [13] , and invasion does appear to develop in an undifferentiated area of intraepithelial disease [106] .
The differing proportion of invasive vulvar Paget disease in the various series (from 0% to 48%) ( Table 2) may reflect referral bias of cases more likely to be referred to tertiary centers. Furthermore the identification of invasive disease may be a result of more thorough histologic sampling of the tumor [59] .
Vulvar Paget Disease as a Manifestation of Primary Underlying Adenocarcinoma of the Vulva
In mammary Paget disease almost all cases reflect the extension of malignant cells into the epidermis, via lactiferous ducts, from an underlying mammary carcinoma: the so-called epidermotropic metastasis [1] . This relationship is generally absent in vulvar Paget disease and association with invasive underlying adenocarcinoma is present in approximately 10% of cases (range = 0-40%) ( Table 2) . Selection bias in different series may result from the differing surgical procedures used. Wide vulvar excision may underestimate the presence of underlying adenocarcinoma with respect to total vulvectomy. A more reliable prevalence of concurrent adeno- 
Association with Other Neoplasms
Patients with vulvar Paget disease are also reported to be at increased risk of other primary neoplasms. The list of associated malignancies includes anal, rectal, colonic, endometrial, cervical ovarian and stomach adenocarcinoma, vaginal and vulvar squamous cell carcinoma, papillary transitional cell carcinoma of the renal pelvis, ureter, bladder and urethra, basal cell skin cancer, lung, breast, and thyroid carcinoma. The reported frequency of associated malignancy is highly variable by site, type, and temporal relationship, and it ranges from 0% to 50% (mean 20%) ( Table 2 ). The prevalence of cancer in these elderly patients is not significantly different from published data for patients from their demographic group [107] , and the association of vulvar Paget disease with cancer may be, for the most part, a secondary effect of the advanced age of these patients [13] . To truly evaluate whether the risk of another malignancy in women with Paget disease is increased, one would need to design a specific study to address this hypothesis. Moreover, the search for additional malignancy would have to be systematic, which it was not in most parts of the series examined.
It should be stressed that perianal or periurethral Paget disease may represent involvement of the vulvar skin by pagetoid extension of a regional neoplasm including anorectal adenocarcinoma or urothelial neoplasia. In these cases of secondary vulvar Paget disease immunohistochemical analysis demonstrates distinctive features.
A systemic work-up for an associated malignancy should be reserved for selected cases. An evaluation including colon-sigmoidoscopy, urethrocystoscopy, chest roentgenogram, intravenous pyelogram, mammogram, cervicovaginal Pap smear, urine cytology, and CAT scan [101] appears too extensive to be applied routinely to patients with only vulvar localization of Paget disease.
TREATMENT
Ideal therapy aims at minimal tissue destruction and low recurrence rate, but some features of vulvar Paget disease interfere with these goals. The treatment and prognosis are closely related to pathologic characteristics of the disease.
Primary Vulvar Intraepithelial Paget Disease
The treatment is wide and deep surgical excision as recommended by most authors [23, 25, 93, 108] . Wide local excision, including a peripheral margin of 1.5-2 cm of skin with normal appearance, is not always easy to achieve while preserving sexual function, normal anatomy, and body image, particularly for excision of lesions at the vaginal side near the urethral orifice. At the same time, deep resection of the lesion is mandatory. Not only the dermis but also all skin appendages that could potentially contain Paget cells should be resected. As no hair follicles or sweat glands extend more than 4.0 mm below the surface of the epidermis [23], excision deeper than this is not recommended. Complete inclusion of skin appendages and histologic examination to search for underlying neoplasms are two reasons that exclude laser vaporization as the sole treatment of vulvar Paget disease [98, 109, 110] . Recently photodynamic therapy [111] has been proposed as a primary treatment of vulvar Paget disease using topical 20% ␦-aminolevulinic acid and Argon dye laser [105] .
Primary Vulvar Paget Disease with Stromal Invasion
Most studies have reported that foci of superficial dermal invasion associated with predominantly intraepithelial vulvar Paget disease did not adversely affect prognosis [14, 20, 59, 67] . The rare reports of metastatic minimally invasive vulvar Paget disease probably describe un-sampled deeper foci of invasion [20, 104] and, up to now, a conservative approach in the treatment of minimally invasive vulvar Paget disease is recommended. It should be emphasized that in the literature there is no consensus for the method of measurement for depth of invasion in vulvar adenocarcinoma.
Vulvar Paget Disease as a Manifestation of an Underlying Primary Cutaneous Adenocarcinoma of
the Vulva These patients, as well as patients with stromal invasion exceeding 1 mm, should be treated with vulvar excision to the fascia of the clinically involved area and bilateral inguinofemoral lymphadenectomy. The clinical course of these patients is much different from intraepithelial vulvar Paget disease. They recur soon after the initial treatment, frequently showing general metastases [14] . It is clear that surgical treatment alone is not enough for these patients because micrometastases seem to exist at the time of surgical excision [14, 94] . For these patients effective systemic therapy is indicated.
Vulvar Paget Disease as Involvement of the Vulvar Skin by a Noncutaneous Internal Neoplasm
In such cases therapy is directed toward treatment of the associated carcinoma, and vulvar Paget disease can be treated with a conservative approach like an intraepithelial lesion. The prognosis depends on the stage and prognostic factors of the associated adenocarcinoma.
Integrated Therapies
There are few data in the literature on radiotherapeutic or chemotherapeutic approaches to locally advanced, recurred, or invasive vulvar Paget disease. The small number of patients treated with chemotherapy (topical bleomycin, mitomycin-C, 5-fluorouracil, cyclophosphamide, doxorubicin, cisplatin, carboplatin, vincristine) as yet allows for no final conclusions about the regimens proposed [14, 112] . Clear inclusion criteria and adequate follow-up time are required to clarify the role of radiation therapy for patients who are not surgical candidates [113] [114] [115] . The clinical evidence does not support the use of chemotherapy and radiotherapy for patients with intraepithelial vulvar Paget disease not associated with invasive carcinoma.
A recent study demonstrated that vulvar Paget disease cells express androgen receptors rather than estrogen or progesterone receptors [116] . Further studies are needed to determine whether androgen receptor status could aid in the therapy of recurrent and invasive vulvar Paget disease.
Margin Control
In primary vulvar Paget disease the clinical visible borders do not completely define the histologically involved area. Therefore a balance between the extent of surgical resection and the probability of leaving Paget cells in the remaining vulvar tissue is difficult to determine. Various types of margin controls have been proposed to reduce local recurrence, including colposcopi- [19, 96] . There is, however, no evidence that intraoperative frozen section margin assessment reduces recurrence or improves survival [93] . Even antibodies to carcinoembryonic antigen, epithelial membrane antigen, and low molecular weight cytokeratins, used to improve Paget cell detection sensitivity, add no value in identifying Paget cells in resection margins that are negative on routine hematoxylin and eosin staining [119] .
Recurrences
The difficulty in defining the margins of vulvar Paget disease lesion extension is closely related to the problem of recurrences: an apparently complete excision of intraepithelial vulvar Paget disease is followed by recurrences, even in skin grafts used to cover the wound after vulvectomy [120] . Patients with recurrent disease are characterized by multiple recurrences [97] . Almost half of the recurrences appear within 18 months from initial treatment [102] with a range from a few months to more than 15 years [13, 15, 83, 101] .
Difficulties in comparing reports arise from the different types of surgical procedures performed and from the state of operative margins, which are often not detailed. The recurrence rate of 15-20% in cases with negative margins increases to 50% or more if surgical margins are involved. Furthermore the mean time to recurrence for patients with negative margins is longer than for those with positive margins [14, 15, 59, 93, 101] . The surgical resection of visibly involved skin and mucosa, with visibly normal skin margins of resection, without frozen section assessment, is a reasonable and effective approach to vulvar cutaneous Paget disease [93] . As the frequency of local recurrence is strongly correlated with the presence of invasive disease [15] we reported in separate tables intraepithelial (Table 3) Because most recurrences of intraepithelial vulvar Paget disease consist entirely of intraepidermal disease, which does not affect survival [7] , and the extent of the initial operation does not correlate with disease recurrence, conservative local excision for intraepithelial lesions is a reasonable consideration in young and old patients.
CONCLUSION
The use of biopsies for any unclear vulvar abnormality gives valuable information at a reasonable cost and prevents delay of diagnosis. When diagnostic difficulty occurs, immunohistochemical studies can be used. The recently proposed vulvar Paget disease subclassification will contribute to the correct diagnosis and appropriate treatment for affected patients. Prognosis is closely related to pathologic characteristics of the disease. Additional molecular genetic studies are needed to better understand the biological behavior of vulvar Paget disease.
